News | October 2, 2025
Shalabh Gupta and Amran Nawaz, Associate Directors in Secretariat’s Global Sports Consulting practice, were recently quoted in an S&P Global article discussing sports team acquisition and valuation trends.
April 28, 2023
BioPharma has experienced significant growth in recent years. This report by Robert Stoner and Jéssica Dutra, prepared for Pfizer, on the BioPharma Economic Impact in the US Economy demonstrates that the BioPharma industry in the United States provides significant value added to the GDP, a significant “multiplier” effect on employment and earnings, and a major R&D presence in the United States and worldwide.
Shalabh Gupta and Amran Nawaz, Associate Directors in Secretariat’s Global Sports Consulting practice, were recently quoted in an S&P Global article discussing sports team acquisition and valuation trends.
Executive Scandals: Navigating Reputational and Financial Risks
Executive Scandals: 2025 Navigating Reputational and Financial Risks, authored by experts from FGS Global and Secretariat, provides a practical framework for boards, legal teams, and compliance professionals. It highlights four core practices including preparation, independent guidance, thorough investigations, and consistent communications that strengthen organizational resilience and protect corporate reputation.
Mid-Year 2025 Update: Nazaha’s Progress in the Fight Against Corruption
As part of its ongoing mandate to enhance transparency and integrity, Saudi Arabia’s Oversight and Anti-Corruption Authority (Nazaha), has continued its efforts. For the six months to June 2025, Nazaha have conducted areas of engagement into new authorities.